Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Clinical trial NCT00296153 · COMPLETED

Trial details

NCT number: NCT00296153
Sponsor: Pronova BioPharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Ischemic Heart Disease

Start date: 2006-02-01
Primary completion: 2006-11-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.